MiniMed 780G System Use in Type 1 Diabetes During Ramadan Intermittent Fasting: A Systematic Literature Review and Expert Recommendations
Diabetes Technology & Therapeutics · 2025-01 · 27 (1) · 72-85
DOI: 10.1089/dia.2024.0200 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Diabetes Technology & Therapeutics, online erschienen am 08.01.2025. Verfasst von Nancy Elbarbary und 14 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes and Endocrinology Unit, Department of Pediatrics, Faculty of Medicine, Ain Shams University, Cairo, Egypt. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Fasting, Islam, Insulin. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
This article offers a systematic literature review (SLR) on the use of the MiniMed 780G automated insulin delivery system (MM780G) in people with type 1 diabetes (PwT1D) during Ramadan intermittent fasting. It also presents consensus recommendations on the use of MM780G during the Ramadan period. The SLR was performed following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses methodology. The recommendations resulted from a consensus-forming process involving a panel of experts. The process considered evidence found in the SLR as well as the expert opinions. In total, six studies were included in the SLR. The evidence and expert opinions led to recommendations related to (a) pre-Ramadan counseling of MM780G users who plan to fast; (b) suggested MM780G settings, meal announcement strategy, and safety aspects during Ramadan (including a contingency plan); and (c) post-Ramadan transition into and out of Eid-al-Fitr festivities. The SLR findings showed that the MM780G maintains glycemic control at target in PwT1D during Ramadan (meeting continuous glucose monitoring–based clinical targets proposed by the International Consensus on Time-in-Range) while ensuring low rates of hypoglycemia and diabetic ketoacidosis. Automated insulin delivery also helps PwT1D fast more days of Ramadan compared with users of other less advanced modalities of treatment. Pre-Ramadan guidance on specific aspects of the MM780G along with the International Diabetes Federation and Diabetes and Ramadan International Alliance counseling guidelines is recommended. There is still a challenge with post-Iftar hyperglycemia, which could potentially be mitigated by following the recommendations outlined in this article.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Diabetes and Endocrinology Unit, Department of Pediatrics, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
- Division of Endocrinology, Department of Internal Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
- Diabetes Center, Dallah Hospital, Riyadh, Saudi Arabia.
- Endocrinology section, Department of Medicine, King Abdulaziz Medical City, King Abdullah International Medical Research Centre, Ministry of National Guards Health Affairs, Jeddah, Saudi Arabia.
- College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia.
- Endocrine Department, Dubai Hospital, Dubai Academic Health Cooperation, Dubai, United Arab Emirates.
ORCID-Profile: Nancy Elbarbary, Abdullah Alguwaihes, Goran Petrovski, Mahmoud Ibrahim, Wael Chaar, Mohammed E Al-Sofiani
Zitieren
APA
Elbarbary, N., Alguwaihes, A., Zarif, H., Hassanein, M., Deeb, A., Petrovski, G., Al Dahash, R., Alamoudi, R., Hussain, S., Ibrahim, M., Shaikh, S., Zainudin, S. B., Chaar, W., van den Heuvel, T., & Al-Sofiani, M. E. (2025). MiniMed 780G System Use in Type 1 Diabetes During Ramadan Intermittent Fasting: A Systematic Literature Review and Expert Recommendations. Diabetes Technology & Therapeutics, 27(1), 72-85. https://doi.org/10.1089/dia.2024.0200
Vancouver
Elbarbary N, Alguwaihes A, Zarif H, Hassanein M, Deeb A, Petrovski G, et al. MiniMed 780G System Use in Type 1 Diabetes During Ramadan Intermittent Fasting: A Systematic Literature Review and Expert Recommendations. Diabetes Technology & Therapeutics. 2025;27(1):72-85. doi:10.1089/dia.2024.0200
BibTeX
@article{Elbarbary2025,
author = {Elbarbary, Nancy and Alguwaihes, Abdullah and Zarif, Hawazen and Hassanein, Mohamed and Deeb, Asma and Petrovski, Goran and Al Dahash, Raed and Alamoudi, Reem and Hussain, Sufyan and Ibrahim, Mahmoud and Shaikh, Shehla and Zainudin, Sueziani Binte and Chaar, Wael and van den Heuvel, Tim and Al-Sofiani, Mohammed E},
title = {MiniMed 780G System Use in Type 1 Diabetes During Ramadan Intermittent Fasting: A Systematic Literature Review and Expert Recommendations},
journal = {Diabetes Technology & Therapeutics},
year = {2025},
volume = {27},
number = {1},
pages = {72--85},
doi = {10.1089/dia.2024.0200}
}
EUVIMED